Trump calls out weight-loss drugs as target of price-cut push

The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its push to lower prescription drug prices.

- DEENA BEASLEY

President Donald Trump's executive order demands that drugmakers cut prices on their products in the coming months to hew more closely to what they charge in other developed countries, or face new regulations and enforcement actions, from export restrictions to tariffs.

At the signing ceremony, Trump described a conversation with a businessman friend who lamented how much more expensive weight-loss treatments cost in the United States.

“I’m in London, and I just paid for this damn fat drug I take,” Trump quoted the man as saying. “I just paid $88 and in New York I paid $1,300. What the hell is going on? ... It’s the same box made in the same plant by the same company.” He didn’t name the medicine.